These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14592856)

  • 1. Introduction. Biochemical basis for disease of the neuromuscular junction.
    Agius MA
    Ann N Y Acad Sci; 2003 Sep; 998():1. PubMed ID: 14592856
    [No Abstract]   [Full Text] [Related]  

  • 2. The kinetics of transmitter release in myasthenia gravis. I. An electrophysiological analysis of the storage of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1972; 12(5):443-88. PubMed ID: 4350884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of the neuromuscular defect in myasthenia (review)].
    Gekhm BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(1):139-44. PubMed ID: 4891871
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuromuscular junction border conflict.
    Naeije G; Legros B; de Beyl DZ
    J Neurol; 2010 Aug; 257(8):1402-3. PubMed ID: 20232207
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolated facial and bulbar paresis: a persistent manifestation of neonatal myasthenia gravis.
    Jeannet PY; Marcoz JP; Kuntzer T; Roulet-Perez E
    Neurology; 2008 Jan; 70(3):237-8. PubMed ID: 18195270
    [No Abstract]   [Full Text] [Related]  

  • 6. [Apropos of the pathogenesis of myasthenia gravis].
    Dolzhenko AT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(3):393-8. PubMed ID: 4299667
    [No Abstract]   [Full Text] [Related]  

  • 7. The neuromuscular junction with special reference to myasthenia gravis.
    Hubbard JI
    Proc Aust Assoc Neurol; 1965; 3():55-60. PubMed ID: 5881782
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylcholine utulization in myasthenia gravis.
    Thesleff S
    Ann N Y Acad Sci; 1966 Jan; 135(1):195-208. PubMed ID: 5221341
    [No Abstract]   [Full Text] [Related]  

  • 9. [The neuromuscular junction in myasthenia. Human and experimental morphological data (author's transl)].
    Fardeau M
    Ann Chir; 1980 Mar; 34(3):140-6. PubMed ID: 6989315
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of incomplete ligation of the nerve on neuromuscular mechanism--appearance of myasthenic pheomenon].
    Shibuya N
    Rinsho Shinkeigaku; 1975 May; 15(5):279-85. PubMed ID: 1238218
    [No Abstract]   [Full Text] [Related]  

  • 11. Restoring balance at the neuromuscular junction.
    Kaminski HJ
    Neurology; 2007 Aug; 69(7):629-30. PubMed ID: 17698782
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.
    Gu D; Wogensen L; Calcutt NA; Xia C; Zhu S; Merlie JP; Fox HS; Lindstrom J; Powell HC; Sarvetnick N
    J Exp Med; 1995 Feb; 181(2):547-57. PubMed ID: 7836911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?
    Lucia A; Maté-Muñoz JL; Pérez M; Foster C; Gutiérrez-Rivas E; Arenas J
    Muscle Nerve; 2007 Jan; 35(1):125-8. PubMed ID: 16967472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular transmission in thyroid disease.
    Norris FH
    Ann Intern Med; 1966 Jan; 64(1):81-6. PubMed ID: 5900786
    [No Abstract]   [Full Text] [Related]  

  • 16. Longstanding right-hand weakness in a patient with myasthenia gravis.
    de Carvalho M; Geraldes R
    Muscle Nerve; 2006 Nov; 34(5):670-1. PubMed ID: 16878322
    [No Abstract]   [Full Text] [Related]  

  • 17. Dagen des oordeels. Pathokinetic mechanisms and molecular messengers (a dramatic view).
    Engel WK
    Arch Neurol; 1979 Jun; 36(6):329-39. PubMed ID: 378196
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.